Loading research…
Nurix Therapeutics, Inc. (NASDAQ: NRIX)
Nurix Therapeutics, Inc. trades on NASDAQ under the symbol NRIX, quoted in USD. The listing is associated with United States. Its sector is Health technology, within Biotechnology. Reported figures retain their financial periods. Market prices and charts are shown separately from dated research.
- Exchange
- NASDAQ
- Country
- United States
- Sector
- Health technology
- Industry
- Biotechnology
- Trading currency
- USD
- ISIN
- US67080M1036
Reported financials
Research date October 28, 2026. Figures below are dated observations, not market quotes.
| Metric | Value | Period | Period end |
|---|---|---|---|
| Revenue | 701,936,000.00 USD | TTM | Aug 31, 2026 |
| Net income | 294,877,000.00 USD | TTM | Aug 31, 2026 |
| Diluted EPS | 2.31 USD | TTM | Aug 31, 2026 |
| Total assets | 702,563,000.00 USD | Annual | Nov 30, 2025 |
| Total debt | 55,730,000.00 USD | Annual | Nov 30, 2025 |
| Gross margin | 97.74% | TTM | Aug 31, 2026 |
| Operating margin | 41.27% | TTM | Aug 31, 2026 |
| Return on equity | 43.99% | TTM | Aug 31, 2026 |
| Return on assets | 34.33% | TTM | Aug 31, 2026 |
| Dividend per share | 0.00 USD | Annual | Nov 30, 2025 |
Stock ScreenerEarnings CalendarDividends CalendarStock investing guide
Data notes
Scores, valuation models and research metrics use dated FOLITIC research. Dates and currencies remain attached to their observations. Missing values are shown as a dash.
Market quotes and charts use the separate market-data display. Saved research prices and model comparisons are not live quotes. Model ranges represent sensitivity scenarios, not confidence intervals or price guarantees.
Listings on different exchanges and different share classes are kept separate. No currency conversion is applied to saved research values.